Previous close | 257.00 |
Open | 256.91 |
Bid | 255.60 x 900 |
Ask | 255.93 x 1800 |
Day's range | 255.49 - 258.93 |
52-week range | 229.40 - 277.29 |
Volume | |
Avg. volume | 1,239,515 |
Market cap | 72.941B |
Beta (5Y monthly) | 0.66 |
PE ratio (TTM) | 40.40 |
EPS (TTM) | 6.33 |
Earnings date | 03 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | 3.48 (1.38%) |
Ex-dividend date | 08 Jun 2022 |
1y target est | 283.67 |
You'll sleep better at night, and you'll also probably get richer than if you were holding cash.
BD's (BDX) new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States to aid lab technicians in prioritizing higher value work.
BD (BDX) expands strategic partnership with Babson Diagnostics that will enable less invasive blood sample collection easier and patient-centric.